Pharmaceutical Industry: Brand Strategy, Sales, and Launch

Name: Pharmaceutical Industry: Brand Strategy, Sales, and Launch
Rating: 4.7 (4 reviews)

Brand strategy, market access & launch — plus field sales mastery and market access in depth: Canada, US & Europe

Created byDavid LL.

Last updated 11/2026

English

English [Auto],

What you'll learn

Master the drug lifecycle, from R&D to commercialization, and identify key business drivers for success.
Develop a robust product positioning and core brand messaging for a novel pharmaceutical asset.
Design a strategic commercial launch plan, including sales force deployment and performance tracking.
Apply core commercial compliance and ethical guidelines to all sales and marketing activities.
Build foundational revenue forecasts and construct a persuasive business case for commercial investment.
Analyze and utilize market data (e.g., prescriptions, market share) to optimize post-launch marketing strategy.
Run a complete pharmaceutical sales call: set a patient-level objective, diagnose the real prescribing barrier, and close on a specific commitment
Handle the four objections reps hear most — efficacy doubts, safety concerns, cost/formulary blocks, and 'my patients do fine' — with word-for-word frameworks
Build and manage a territory plan: tier prescribers by potential and movability, set call frequencies, and write a measurable first-90-days plan
Sell compliantly and through the whole system: stakeholder and KOL mapping, access and prior-authorization pathways, virtual selling, and PhRMA/PAAB guardrails
Map the market access pathway in Canada (CADTH, INESSS, pCPA), the US (PBMs, formularies), the UK (NICE), Germany (AMNOG) and France (HAS)
Explain how international reference pricing and launch sequencing decisions in one market raise or destroy value in others
Build the evidence package — economic models, budget impact and real-world evidence — that wins formulary listings
Design a brand's market access plan: price corridor, negotiation fallbacks, and the indicators that trigger a change of course

Course content

25 sections • 145 lectures • 11h 19m total length

The Pharmaceutical Value Chain6:29
Explore the pharmaceutical value chain from discovery through phase three trials, regulatory approval, manufacturing, and market access, and examine the four industry players and the pricing dilemma.
The Pharmaceutical Value Chain Study Guide5:54
Business Models in Pharma7:11
Explore why pharma shifted from blockbusters to niche busters, driven by the patent cliff, Orphan Drug Act incentives, and high R&D costs.
Business Models in Pharma Study Guide5:25
Strategy Memo: The Pharmaceutical Industry's Pivot to Specialty Commercial Model5:47
The Nichebuster Thesis: The New Paradigm of Specialty & Orphan Drugs5:49
The Nichebuster Thesis: The New Paradigm of Specialty & Orphan Drugs6:16
Core Commercial Functions7:37
Marketing, sales, and commercial operations form an integrated engine that moves a new therapy from lab to patient by aligning strategy, execution, and data-driven insights.
Core Commercial Functions Study Guide4:43
Foundations Check

Drug Discovery & Pre-Clinical Assessment6:11
Unpack unmet medical need, market size, and risk-adjusted net present value (NPV) to explain why only a few drug ideas survive pre-clinical work and become billion-dollar blockbusters.
Drug Discovery & Pre-Clinical Assessment Study Guide5:30
Commercial Input to Clinical Trials6:46
Define how a blockbuster drug emerges from a strategic blueprint called the target product profile, selecting primary, secondary, surrogate, and comparative endpoints to satisfy the FDA, payers, and physicians.
Commercial Input to Clinical Trials Study Guide5:42
Regulatory Strategy and Intellectual Property5:51
Explore how regulatory strategy and intellectual property shape pharma profits, from FDA review timelines and priority pathways to the core patent and patent thicket guarding a drug's time-to-market window.
Regulatory Strategy and Intellectual Property Study Guide5:27
Development & Commercial Lens Check

Business Development and Inorganic Growth7:01
Explore how big pharma uses strategic acquisitions and licensing to outpace the patent cliff, balancing due diligence, risk-adjusted valuation, and AI-driven discovery for global expansion.
BD quiz6:05
M&A quiz7:15
Deconstructing a Pharma Deal: From Term Sheet to Close6:43
Deconstructing a Pharma Deal: A Guide to Upfronts, Milestones, and Royalties5:12
Investment Memorandum: Valuation and Strategic Exits in the Biotechnology Sector6:30
Investment Memorandum: Valuation and Strategic Exits in the Biotechnology Sector10:13
The Billion-Dollar Bet5:39
Explore how biopharma valuation gaps between startups and investors shape mergers and acquisitions and strategic partnerships, showing why alliances often outpace takeovers.
Pharma's High-Stakes Handshake5:13

Segmentation, Targeting, and Positioning (STP)4:45
Apply the stp framework to map healthcare segments and target audiences, then craft positioning through storytelling. Align teams for a unified message to doctors, payers, patients, and pharmacists.
Segmentation, Targeting, and Positioning (STP) Study Guide5:20
Creating the Marketing Mix (The 4 Ps)7:56
The marketing mix in pharma turns a lab breakthrough into patient access by aligning product, place, and promotion through a unified strategy, ensuring benefits justify risks and compliant storytelling.
Creating the Marketing Mix (The 4 Ps) Study Guide5:35
Digital and Omnichannel Marketing5:10
Explore how pharma embraces omnichannel marketing with connected, compliant, data-driven strategies that balance promotional and non-promotional content, ensure MLR approvals, and measure ROI.
Digital and Omnichannel Marketing Study Guide6:20
Brand Strategy Check

Launch Planning: The Critical Path10:46
Plan an 18-month pre-launch countdown to build a billion-dollar commercial army, sizing, structuring, and mapping territories with top-down and bottom-up methods, including cams and MSLs for formulary access.
Launch Planning: The Critical Path Study Guide5:46
Sales Force Sizing and Deployment6:02
Explore how to size and deploy pharma sales forces, from infantry vs special ops models to workload math, key account management, and omnichannel integration.
Sales Force Sizing and Deployment Study Guide4:48
Pharmaceutical Sales Force Deployment: A Strategic Plan6:02
Pharmaceutical Sales Force Deployment: A Strategic Plan7:09
Post-Launch Performance and Lifecycle Management5:49
Monitor KPIs and TRX from launch to gauge adoption, market share, and access. Drive lifecycle management to extend value through new indications and improved formulations for long-term competitive advantage.
Post-Launch Performance and Lifecycle Management Study Guide6:01
Measuring Success: How Pharmaceutical Companies Track a New Drug's Performance3:54
Measuring Success: How Pharmaceutical Companies Track a New Drug's Performance3:33
Post-Launch Strategic Plan: Lifecycle Management and Market Defense5:57
Post-Launch Strategic Plan: Lifecycle Management and Market Defense6:40
A Tale of Two Sales Forces: Primary Care vs. Specialty Pharma3:53
A Tale of Two Sales Forces: Primary Care vs. Specialty Pharma4:49
Key Account Management: Winning the Account, Not Just the Call4:49
Key Account Management: Knowledge Check
Inside the Payer Playbook: Rebates, Utilization Controls & Coverage Economics4:57
Inside the Payer Playbook: Rebates, Utilization Controls & Coverage Economics5:01
Copay Support in Practice: Cards, Accumulators, and Maximizers6:02
Copay Support in Practice: Cards, Accumulators, and Maximizers7:35
Patient Access, Adherence, and the Pharma Ecosystem7:56
Explore how copay accumulators and manufacturer assistance shape patient access and adherence to expensive specialty drugs, the rise of patient support hubs, and the push to redesign the pharma ecosystem.
Launch Excellence Check

Forecasting and Business Case Development6:11
Forecast the drug's performance using a waterfall model, convert volume to net sales, and build a data-driven business case to secure funding with a compelling NPV justification.
Pharmaceutical Forecast Model: Governance and Validation Plan4:31
Pharmaceutical Forecast Model: Governance and Validation Plan5:47
Demystifying the Pharmaceutical Revenue Forecast: A Beginner's Guide4:05
Demystifying the Pharmaceutical Revenue Forecast: A Beginner's Guide4:22
Forecasting and Business Case Development Study Guide5:38
Commercial Compliance and Ethics6:29
Navigate the pharma compliance landscape, balancing commercial goals with patient protection through accuracy, transparency, integrity, and accountability. Learn about anti-kickback statute and Sunshine Act, fair balance, and MLR review.
Commercial Compliance and Ethics Study Guide4:51
Medical Affairs & the MSL: The Scientific Side of Commercial Success4:39
Medical Affairs & the MSL: Knowledge Check
The Future of Pharma Commercialization6:11
AI-powered commercialization reshapes pharma from mass blockbuster to hyper personalized therapies. AI copilots guide sales and marketing with doctor data, patient outcomes, and value-based contracts.
The Future of Pharma Commercialization Study Guide5:05
Strategic Plan: Integrating Advanced Real-World Evidence (RWE) Analytics7:50
Strategic Plan: Integrating Advanced Real-World Evidence (RWE) Analytics12:28
Lighting the Way: How Digital Technology Is Revolutionizing Treatment4:08
Lighting the Way: How Digital Technology Is Revolutionizing Treatment5:53
Understanding the Pharmaceutical "Patent Cliff"6:29
Understanding the Pharmaceutical "Patent Cliff"8:44
The Data Revolution in Medicine8:14
Drive the future of medicine with real world evidence from health records, claims, and wearables, using AI to enable smarter trials, synthetic controls, and proven payer value.
Leadership & Trends Check

Anatomy of a Great Sales Call4:40
Pre-Call Planning & Territory Management3:59
Your First 90 Days
Questions That Sell: Uncovering the Real Prescribing Barrier3:43
Objection Handling Masterclass4:12
Handle This Objection
Selling Against the Competition3:58
Field Skills Check: Calls, Barriers & Objections
Beyond the Doctor: Stakeholder & KOL Mapping3:30
Selling Through Access Barriers4:19
Virtual & Hybrid Selling3:30
The Numbers: Sales KPIs, Ride-Alongs & Coaching3:37
Guardrails: Field Compliance & Ethics4:11
Field Sales Mastery: Final Check

Market Access Decoded: How a Drug Actually Gets Paid For5:16
Canada I: HTA Gatekeepers — CADTH & INESSS, From Dossier to Recommendation4:52
Canada II: pCPA Negotiations, Public Plans & Private Payers — Getting Listed4:46
Map Your Market: Access Pathway Brief
United States I: The PBM Machine — Formularies, Tiers, Rebates & Gross-to-Net4:49
United States II: Utilization Management — Prior Auth, Step Therapy & Specialty4:13
United Kingdom: NICE & the NHS — Cost-Effectiveness as the Price of Entry5:57
Access Systems Check: Canada, US & the UK
Germany: AMNOG & the G-BA — Early Benefit Assessment and the Free-Pricing Year5:15
France: HAS, ASMR Ratings & CEPS — Negotiating Price the French Way4:53
The EU HTA Regulation: Joint Clinical Assessments and What Changes for Launches4:15
Price It Right: Launch Sequence Challenge
Pricing Strategy: Launch Sequencing & International Reference Pricing4:48
Evidence That Wins Listings: Models, Budget Impact & Real-World Evidence6:36
Access Strategy in Practice: Building the Access Plan for a New Brand4:52
Market Access in Depth: Final Check

The Annual Brand Plan: From Situation Analysis to Tactical Calendar4:49
Market Research & Customer Insights: Finding the Insight That Moves Prescribing4:59
Competitive Intelligence & War-Gaming: Planning for the Competitor's Next Move4:40
Building the Brand Message House: From Positioning to a Story That Sticks4:22
Brand Forecasting Meets Planning: Setting Targets the Team Can Defend4:13
Brand Plan on a Page: Presenting and Defending Your Plan4:40
Brand Planning in Practice: Final Check
Draft Your Brand Plan on a Page

Requirements

No prior commercial pharma experience is required. This course is designed for aspiring and current professionals.
A general understanding of biology or healthcare concepts is helpful but not mandatory.
A strong interest in the business, strategy, and marketing side of the healthcare industry.

Description

*This course contains the use of artificial intelligence*
This comprehensive course provides the essential knowledge and strategic frameworks for individuals aspiring to, or currently working in, the dynamic commercial side of the pharmaceutical and biotech industries. If you want to understand how a promising molecule transforms into a market-leading product, this is the course for you.

We cover the journey from late-stage development through market entry and long-term brand management — including the market access pathway that decides whether patients can actually get the product.

What You Will Master:

Commercial Foundations: You'll begin by mastering the pharmaceutical value chain, understanding key business models, and identifying the critical roles played by Marketing, Sales, and Commercial Operations. Learn how to look at a pipeline asset with a strategic commercial lens.
Brand Strategy & Positioning: Learn the core marketing skills required to succeed in pharma. This includes conducting market sizing, developing a compelling Target Product Profile (TPP), and creating an irresistible Brand Story that resonates with physicians, patients, and pharmacists. We dive deep into the strategic process of Segmentation, Targeting, and Positioning (STP).
Sales and Launch Excellence: The course provides a rigorous, step-by-step guide to developing and executing a successful drug launch. You will learn the critical milestones of a 12-18 month pre-launch plan, how to determine optimal sales force sizing, deployment strategy, and the critical importance of Key Account Management (KAM).
The Regulatory Imperative: Success in pharma is predicated on compliance. A dedicated module teaches you the importance of Intellectual Property (IP), ethical promotion, and strictly adhering to regulations like anti-kickback statutes and transparency laws, ensuring your commercial actions are always compliant.
Future-Proofing Your Career: Finally, we cover critical business skills, including developing robust revenue forecasts and building data-driven business cases for investment. We conclude with a look at how technologies like AI are shaping the future of sales and marketing in healthcare.

By the end of this course, you will possess a strategic, integrated view of pharmaceutical commercialization that is highly valued by global biopharma employers.

Who this course is for:

University students (PharmD, MBA, Life Sciences) and recent graduates seeking roles in Pharma Marketing or Sales.
Current pharmaceutical or biotech employees looking to transition into a commercial role (e.g., from R&D or QA).
Consultants, financial analysts, or investors needing a deep, strategic understanding of pharmaceutical launches.
Healthcare professionals (nurses, pharmacists) interested in the business strategies behind the medicines they use.

Pharmaceutical Industry: Brand Strategy, Sales, and Launch

What you'll learn

Explore related topics

Course content

Foundations of Commercial Pharma9 lectures • 55min

Drug Development & The Commercial Lens6 lectures • 35min

Business Development & Licensing (BD&L)9 lectures • 1hr

Brand Strategy and Marketing6 lectures • 35min

Market Access4 lectures • 31min

Commercial Launch and Sales Excellence20 lectures • 1hr 57min

Commercial Leadership and Future Trends18 lectures • 1hr 52min

Field Sales Mastery: Rep Tactics That Win10 lectures • 40min

Market Access in Depth: Canada, US & Europe12 lectures • 1hr 1min

Brand Planning in Practice6 lectures • 28min

Requirements

Description

Who this course is for: